TFAP2B: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
 
imported>Graeme Bartlett
m (→‎Further reading: clean up, replaced: restrospectively → retrospectively)
 
Line 20: Line 20:
*{{cite journal  |vauthors=Nordquist N, Göktürk C, Comasco E, etal |title=The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents |journal=Obesity (Silver Spring) |volume=17 |issue= 9 |pages= 1762–7 |year= 2009 |pmid= 19325541 |doi= 10.1038/oby.2009.83 }}
*{{cite journal  |vauthors=Nordquist N, Göktürk C, Comasco E, etal |title=The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents |journal=Obesity (Silver Spring) |volume=17 |issue= 9 |pages= 1762–7 |year= 2009 |pmid= 19325541 |doi= 10.1038/oby.2009.83 }}
*{{cite journal  |vauthors=Prichard ZM, Jorm AF, Mackinnon A, Easteal S |title=Association analysis of 15 polymorphisms within 10 candidate genes for antisocial behavioural traits |journal=Psychiatr. Genet. |volume=17 |issue= 5 |pages= 299–303 |year= 2007 |pmid= 17728669 |doi= 10.1097/YPG.0b013e32816ebc9e }}
*{{cite journal  |vauthors=Prichard ZM, Jorm AF, Mackinnon A, Easteal S |title=Association analysis of 15 polymorphisms within 10 candidate genes for antisocial behavioural traits |journal=Psychiatr. Genet. |volume=17 |issue= 5 |pages= 299–303 |year= 2007 |pmid= 17728669 |doi= 10.1097/YPG.0b013e32816ebc9e }}
*{{cite journal  |vauthors=Michelon L, Meira-Lima I, Cordeiro Q, etal |title=Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder |journal=Neurosci. Lett. |volume=403 |issue= 3 |pages= 288–93 |year= 2006 |pmid= 16787706 |doi= 10.1016/j.neulet.2006.05.001 }}
*{{cite journal  |vauthors=Michelon L, Meira-Lima I, Cordeiro Q, etal |title=Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and retrospectively scored response to lithium prophylaxis in bipolar disorder |journal=Neurosci. Lett. |volume=403 |issue= 3 |pages= 288–93 |year= 2006 |pmid= 16787706 |doi= 10.1016/j.neulet.2006.05.001 }}
*{{cite journal  |vauthors=Fogu G, Bandiera P, Cambosu F, etal |title=Pure partial trisomy of 6p12.1-p22.1 secondary to a familial 12/6 insertion in two malformed babies |journal=Eur J Med Genet |volume=50 |issue= 2 |pages= 103–11 |year=  2007|pmid= 17185054 |doi= 10.1016/j.ejmg.2006.11.002 }}
*{{cite journal  |vauthors=Fogu G, Bandiera P, Cambosu F, etal |title=Pure partial trisomy of 6p12.1-p22.1 secondary to a familial 12/6 insertion in two malformed babies |journal=Eur J Med Genet |volume=50 |issue= 2 |pages= 103–11 |year=  2007|pmid= 17185054 |doi= 10.1016/j.ejmg.2006.11.002 }}
*{{cite journal  |vauthors=Hensch T, Wargelius HL, Herold U, etal |title=Electrophysiological and behavioral correlates of polymorphisms in the transcription factor AP-2beta coding gene |journal=Neurosci. Lett. |volume=436 |issue= 1 |pages= 67–71 |year= 2008 |pmid= 18358611 |doi= 10.1016/j.neulet.2008.02.062 }}
*{{cite journal  |vauthors=Hensch T, Wargelius HL, Herold U, etal |title=Electrophysiological and behavioral correlates of polymorphisms in the transcription factor AP-2beta coding gene |journal=Neurosci. Lett. |volume=436 |issue= 1 |pages= 67–71 |year= 2008 |pmid= 18358611 |doi= 10.1016/j.neulet.2008.02.062 }}

Latest revision as of 10:17, 21 September 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Transcription factor AP-2 beta also known as AP2-beta is a protein that in humans is encoded by the TFAP2B gene.[1][2]

Function

AP-2 beta is a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor.[3]

Clinical significance

Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives.[3]

References

  1. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hofstädter F, Schüle R, Buettner R (1 September 1995). "Cloning and characterization of a second AP-2 transcription factor: AP-2 beta". Development. 121 (9): 2779–88. PMID 7555706.
  2. Williamson JA, Bosher JM, Skinner A, Sheer D, Williams T, Hurst HC (July 1996). "Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors". Genomics. 35 (1): 262–4. doi:10.1006/geno.1996.0351. PMID 8661133.
  3. 3.0 3.1 "Entrez Gene: transcription factor AP-2 beta (activating enhancer binding protein 2 beta)".

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.